Patent · US Expired

Xanthine epoxides as A.sub.1 adenosine receptor agonists and antagonists

US5631260A · kind A · utility

14Cited by
6References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 28, 1994
Grant dateMay 20, 1997
Priority date
Expiry dateOct 28, 2014

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D473/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Xanthine derivatives, and compositions comprising those compounds, are potent selective antagonists of adenosine receptors. The derivatives and compositions are used to treat conditions, including certain cardiac arrhythmias. The compounds, specifically, are C-8 epoxide derivatives of xanthine having the general formulae of: ##STR1## wherein R.sub.1 and R.sub.2 are the same or different, and can be H or an alkyl group of 1-4 carbons, and n=0-4; and ##STR2## wherein R.sub.1 and R.sub.2 are the same or different, and can be H or an alkyl group of 1-4 carbons, R.sub.3 is either O or (CH.sub.2).sub.1-4, and n=0-4.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.